Please use this identifier to cite or link to this item:
|Title:||Use of magnetic resonance imaging-guided radiotherapy for breast cancer: a scoping review protocol.||Austin Authors:||Elliott, Sarah;Berlangieri, Alexandra ;Wasiak, Jason;Chao, Michael ;Foroudi, Farshad||Affiliation:||Radiation Oncology
Olivia Newton-John Cancer Wellness and Research Centre
|Issue Date:||1-Feb-2021||metadata.dc.date:||2021-02-01||Publication information:||Systematic Reviews 2021; 10(1): 44||Abstract:||In recent years, we have seen the incorporation of magnetic resonance imaging (MRI) simulators into radiotherapy centres and the emergence of the new technology of MR linacs. However, the significant health care resources associated with this advanced technology impact immediate widespread use and availability. There are currently limited studies to demonstrate the clinical effectiveness and inform decision-making on the use of MRI in radiotherapy. The objective of this scoping review is to identify and map the existing evidence surrounding the clinical implementation of MRI-guided radiotherapy in patients with breast cancer. It also aims to identify challenges and knowledge gaps in the literature. We will perform a comprehensive search in MEDLINE and EMBASE databases from January 2010 onwards. Grey literature sources will include the WHO International Clinical Trials Registry Platform. We will include systematic reviews, randomised and non-randomised controlled studies published in English. Literature should examine the use of magnetic resonance imaging-guided radiotherapy in adults with breast cancer, regardless of cancer stage or severity. Two reviewers will independently screen all titles, abstracts and full-text reports. Data will be extracted and summarised using qualitative (e.g. content and thematic analysis) methods and presented in tables. The results from this review will consolidate the evidence surrounding MRI-guided radiotherapy for breast cancer, contributing to the development and optimisation of patient selection, simulation, planning, treatment delivery, quality assurance and research, to help improve patient outcomes, cancer care and treatment for women with breast cancer. The protocol is available on Open Science Framework at DOI https://doi.org/10.17605/OSF.IO/8TEV6.||URI:||https://ahro.austin.org.au/austinjspui/handle/1/25802||DOI:||10.1186/s13643-021-01594-9||ORCID:||0000-0002-7500-8483||PubMed URL:||33526097||Type:||Journal Article||Subjects:||Breast cancer
|Appears in Collections:||Journal articles|
Show full item record
checked on Jul 2, 2021
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.